PPTA Twitter

PlasmaProteins
PlasmaProteins . @DonCoppo — donors definitely deserve our gratitude for the dedication they show in supporting people living with rare, serious, & chronic diseases. With our friends at @HIYDglobal , we all agree #PlasmaDonorsSaveLives ! twitter.com/DonCoppo/status/1121060045888868358
1 day ago.
PlasmaProteins
PlasmaProteins It’s important to understand that #plasma used to manufacture #plasmaprotein therapies is intrinsically different from blood components used for transfusion. Differences include the way that plasma is collected & the complexities of the production process. bit.ly/2Qo4bsI
1 day ago.

PPTA Presents at ACBTSA Meeting

The 48th meeting of the U.S. Department of Health & Human Services (HHS) Advisory Committee for Blood & Tissue Safety & Availability (ACBTSA) was held on Nov. 28-29.

The RAND Corporation presented a research report on the HHS sponsored study, "Toward a Sustainable Blood Supply in the United States: An Analysis of the Current System and Alternatives for the Future," which covered RAND’s research, findings, outlook, and recommendations. PPTA's comments focused on re-evaluating requirements for donor screening assays in light of the few manufacturers in the U.S. market. ACBTSA also heard results of the 2015 National Blood Collection and Utilization Survey from the Centers for Disease Control & Prevention as well as an update on the Nov. 17-18 Blood Products Advisory Committee meeting from the U.S. Food & Drug Administration. ACBTSA discussed the RAND report and developed appropriate, unanimous findings and recommendations for HHS consideration. The PPTA Vice President, Global Regulatory Policy, serves on ACBTSA.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100